August 2023
Requirements and codes changed for some medical benefit drugs
What you need to know
We’ve added requirements for some medical drugs, and this article provides an overview. Health care providers also can use our comprehensive drug lists to find the updated requirements.
Blue Cross Blue Shield of Michigan and Blue Care Network encourage proper utilization of high-cost medications that are covered under the medical benefit. As part of this effort, we maintain comprehensive lists of requirements for our members.
In April, May and June 2023, we added requirements for some medical benefit drugs. In addition, some drugs were assigned new HCPCS codes.
Changes in requirements
For Blue Cross commercial and BCN commercial members: We added prior authorization requirements, site-of-care requirements or both as follows:
HCPCS code |
Brand name |
Generic name |
Requirement |
Prior authorization |
Site of care |
J3590** |
Elfabrio® |
pegunigalsidase alfa-iwxj |
✓ |
|
J3590** |
Omisirge® |
omidubicel-onlv |
✓ |
|
J3590** |
Qalsody™ |
tofersen |
✓ |
|
J3590** |
Vyjuvek™ |
beremagene geperpavec-svdt |
✓ |
|
For Medicare Plus Blue℠ and BCN Advantage℠ members: We added prior authorization requirements as follows:
HCPCS code |
Brand name |
Generic name |
For dates of service on or after |
J3590** |
Syfovre™ |
pegcetacoplan injection |
April 3, 2023 |
J9029 |
Adstiladrin® |
nadofaragene firadenovec-vncg |
May 1, 2023 |
J3590** |
Lamzede® |
velmanase alfa |
May 1, 2023 |
Code changes
The table below shows HCPCS code changes that were effective April 1, 2023, for the medical benefit drugs we manage.
New HCPCS code |
Brand name |
Generic name |
Q5128 |
Cimerli™ |
ranibizumab-eqrn |
Q5130 |
Fylnetra® |
pegfilgrastim-pbbk |
J1411 |
Hemgenix® |
etranacogene dezaparvovec-drlb |
J1449 |
Rolvedon™ |
eflapegrastim-xnst |
J1747 |
Spevigo® |
spesolimab-sbzo |
Q5127 |
Stimufend® |
pegfilgrastim-fpgk |
C9149 |
Tzield™ |
teplizumab-mzwv |
Q5129 |
Vegzelma® |
bevacizumab-adcd |
J0218 |
Xenpozyme™ |
olipudase alfa-rpcp |
Drug lists
For additional details, see the following drug lists:
These lists are also available on the following pages of the ereferrals.bcbsm.com website:
Additional information about these requirements
We communicated these changes previously through provider alerts that contain additional details.
You can view the provider alerts on ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal, availity.com.***
Additional information about Blue Cross commercial groups
For Blue Cross commercial groups, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under the medical benefit. To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group list. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.
Note: Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust (non-Medicare) members don't participate in the standard prior authorization program.
Reminder
An authorization approval isn’t a guarantee of payment. Health care providers need to verify eligibility and benefits for members.
**May be assigned a unique code in the future.
***Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website.
Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services. |